Akèy › Metiyè › Medical Scientists, Except Epidemiologists › Indianapolis, IN
Medical Scientists, Except Epidemiologists nan Indianapolis, IN: Salè H-1B
147 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Indianapolis, IN. Salè baz medyàn ofri $68,964; mwatye mitan $61,884–$83,000.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $65,000 |
| Nivo II (kalifye) | $82,500 |
| Nivo III (eksperyans) | $128,125 |
| Nivo IV (plen kompetans) | $174,046 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Indiana University Indianapolis | 69 | $68,215 |
| Indiana University Purdue University Indianapolis | 47 | $63,920 |
| Eli Lilly and Company | 21 | $145,346 |
| Purdue University | 3 | $58,812 |
| Indiana Biosciences Research Institute, Inc. | 2 | $120,000 |
| IU Health Care Associates | 2 | — |
| Neurohealth Ltd LLC | 1 | $60,798 |
| Cook Research Inc. | 1 | $100,000 |
| IQVIA Laboratories LLC | 1 | $121,673 |
Tit travay
- Postdoctoral Fellow58
- Assistant Research Professor38
- Assistant Research Scientist5
- Senior Staff Scientist2
- Sr. Director - Clinical Development2
- Assistant Professor of Clinical Pathology & Laboratory Medic2
- Assistant Professor Medical Physicist2
- Assistant Professor2
- Executive Director - Clinical Research Physician2
- Post-Doctoral Research Assistant2
- Assistant Research Professor of Medicine2
- Research Data Analyst2
- Post-Doctoral Scientist - Neurodegeneration2
- Clinical Design Physician-Immunology2
- Medical Scientist2
Pwonse H-1B nan Indianapolis, IN →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).